The topical fluralaner solution is cleared for the prevention and treatment of new world screwworm infestation
Growing patent filings and tier-2 innovators reflect expanding national research base
Peapod Bio’s proprietary technologies can efficiently identify inhibitors and binding molecules for virtually any target
DBT and BIRAC have partnered with CEPI since 2019, for cooperation on vaccine development for diseases of epidemic potential
The technology is intended to support imaging-based training, protocol optimisation and surgical planning
The BlueSeal Horizon 3.0T platform incorporates advanced magnet technology
The partnership targets breakthroughs in Alzheimer’s disease, diabetes, cancer, and cell and gene therapy
Jaypirca is the first and only FDA-approved non-covalent (reversible) BTK inhibitor
The company introduced the ExcelSign E12 and E17 modular patient monitors, the Relife 1000 biphasic defibrillator, and a new OT charting software
Subscribe To Our Newsletter & Stay Updated
